Liberty Military Housing Names John Corriher Vice President of OperationsHuntington Beach, CA, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Liberty Military Housing (Liberty) announced today the promotion of John Corriher to Vice President of Operations, where he will continue to guide operational performance across Liberty’s national portfolio, with an expanded focus on financial oversight, team development, and long-term operational excellence. In his new role, he will work closely with regional teams to strengthen operational consistency, elevate service standards, and support Liberty’s mission of providing high-quality housing for service members and their families.
Goodway Group Named a 2026 Ad Age Best Places to Work for Sixth Consecutive YearThe accolade reflects Goodway Group’s focus on building a culture that values curiosity, initiative, and real-world impact
TRIP.COM ALERT: Bragar Eagel & Squire, P.C. is Investigating Trip.com Group Limited on Behalf of Trip.com Stockholders and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Trip.com (TCOM) To Contact Him Directly To Discuss Their Options
Bacterial Mechanism That Could Help Prevent and Treat Lyme Arthritis Identified by New Bay Area Lyme Foundation–Supported StudyResearch published in PLOS Pathogens highlights a cell wall–driven trigger of joint inflammation, pointing to new ways to target Lyme arthritis
U.S. Small Business Administration Releases 2025 Annual ReportTrump SBA Highlights Historic Year of Main Street Growth and Optimism driven by Tax Cuts, Deregulation, Fair Trade and Record Lending
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Varonis Systems, Inc. of Class Action Lawsuit and Upcoming Deadlines - VRNSNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. (“Varonis” or the “Company”) (
NASDAQ: VRNS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BigBear.ai Holdings, Inc. - BBAINEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (
NYSE: BBAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Klarna Group PLC of Class Action Lawsuit and Upcoming Deadlines - KLARNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Klarna Group PLC (“Klarna” or the “Company”) (
NYSE: KLAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fermi Inc. of Class Action Lawsuit and Upcoming Deadlines - FRMINEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fermi Inc. (“Fermi” or the “Company”) (
NASDAQ: FRMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Smart Digital Group Limited of Class Action Lawsuit and Upcoming Deadlines - SDMNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Smart Digital Group Limited (“Smart Digital” or the “Company”) (
NASDAQ: SDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Smartsheet Inc. of Class Action Lawsuit and Upcoming Deadlines - SMARNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Smartsheet Inc. (“Smartsheet” or the “Company”) (
NYSE: SMAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGLNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (
NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTMNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. (“Quantum” or the “Company”) (
NASDAQ: QNTM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TILNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. (“Instil” or the “Company”) (
NASDAQ: TIL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NCH and Nicklaus Children’s Announce Major Plans to Expand Care for Women and ChildrenNaples, FL., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Naples Comprehensive Health (NCH) and Nicklaus Children’s Hospital today announced a major expansion of care for women and children in Southwest Florida, made possible by a visionary gift from Bill and Julia Van Domelen Foundation. This investment will establish the Van Domelen Institute for Women and Children and support construction of the Van Domelen Pavilion for Women and Children on the NCH North Hospital campus.
Overworld Unveils Real-Time Diffusion World Model for Playable, AI-Native WorldsPROVIDENCE, R.I., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Today, Overworld (formerly Wayfarer Labs) announced the release of a research preview of its local-first diffusion world model. This model is an early, experimental system targeted toward researchers, engineers, and builders. The company is inviting these audiences to explore how diffusion-based world models can operate entirely on-device and at frame rates suitable for play.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORTNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (
NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIONEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. (“Zenas” or the “Company”) (
NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apogee Enterprises, Inc. - APOGNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. (“Apogee” or the “Company”) (
NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Charming Medical Ltd. of Class Action Lawsuit and Upcoming Deadlines - MCTANEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Charming Medical Ltd. (“Charming” or the “Company”) (
NASDAQ: MCTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDTNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. (“Ardent” or the “Company”) (
NYSE: ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - ASTSINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, In, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AST SpaceMobile, Inc. (“AST” or the “Company”) (
NASDAQ: ASTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coupang, Inc. of Class Action Lawsuit and Upcoming Deadlines - CPNGNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Coupang, Inc. (“Coupang” or the “Company”) (
NYSE: CPNG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Africa Bitcoin Corporation to Present at the Digital Asset Treasury Conference Virtual Investor Conference January 27thAfrica Bitcoin Corporation invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Cosmos Launches Dedicated APAC Distributor to Expand Global Business Central Reporting ReachCosmos Data Technologies, the first and only cloud reporting and analytics solution built specifically for Microsoft Dynamics 365 Business Central, today announced a new distribution agreement with Cosmos Data Technologies APAC Limited (“Cosmos APAC”), a newly formed entity that will serve as the exclusive distributor and primary services provider for Cosmos across the Asia-Pacific (APAC) region.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sigma Lithium Corporation - SGMLNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sigma Lithium Corporation (“Sigma Lithium” or the “Company”) (
NASDAQ: SGML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRANEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (
NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bath & Body Works, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBWINEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (“Bath & Body Works” or the “Company”) (
NYSE: BBWI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDANEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”) (
NASDAQ: VNDA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trip.com Group Limited - TCOMNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Trip.com Group Limited (“Trip.com” or the “Company”) (
NASDAQ: TCOM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teleflex Incorporated - TFXNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated (“Teleflex” or the “Company”) (
NYSE: TFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in F5, Inc. of Class Action Lawsuit and Upcoming Deadlines - FFIVNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. (“F5” or the “Company”) (
NASDAQ: FFIV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aquestive Therapeutics, Inc. - AQSTNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (
NASDAQ: AQST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of First Solar, Inc. - FSLRNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. (“First Solar” or the “Company”) (
NASDAQ: FSLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Community Bank & Trust – West Georgia Caps Historic Turnaround, Emerges as National Standout in 2025The 125-year-old institution posts record earnings, 400% growth in non-interest income, and breakthrough SBA securitizations
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Integer Holdings Corporation of Class Action Lawsuit and Upcoming Deadlines - ITGRNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (“Integer” or the “Company”) (
NYSE: ITGR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gauzy Ltd. of Class Action Lawsuit and Upcoming Deadlines - GAUZNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Gauzy Ltd. (“Gauzy” or the “Company”) (
NASDAQ: GAUZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bitdeer Technologies Group of Class Action Lawsuit and Upcoming Deadlines - BTDRNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bitdeer Technologies Group (“Bitdeer” or the “Company”) (
NASDAQ: BTDR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Blue Owl Capital Inc. of Class Action Lawsuit and Upcoming Deadlines - OWLNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (
NYSE: OWL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alexandria Real Estate Equities, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARENEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (
NYSE: ARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sprouts Farmers Market, Inc. of Class Action Lawsuit and Upcoming DeadlinesNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (
NASDAQ: SFM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in StubHub Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – STUBNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against StubHub Holdings, Inc. (“StubHub” or the “Company”) (
NYSE: STUB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Pomerantz Law Firm Announces the Filing of a Class Action Against CoreWeave, Inc. and Certain Officers – CRWVNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CoreWeave, Inc. (“CoreWeave” or the “Company”) (
NASDAQ: CRWV) and certain officers. The class action, filed in the United States District Court for the Western District of Texas, and docketed under 26-cv-00355, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CoreWeave securities between March 28, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Jayud Global Logistics Ltd. of Class Action Lawsuit and Upcoming Deadlines - JYDNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Jayud Global Logistics Ltd. (“Jayud” or the “Company”) (
NASDAQ: JYD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming DeadlinesNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NowRx, Inc. (“NowRx” or the “Company”). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Transaction in Own SharesTransaction in Own Shares
Pomerantz Law Firm Announces the Filing of a Class Action Against DeFi Technologies Inc. and Certain Officers – DEFTNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DeFi Technologies Inc. (“DeFi Technologies” or the “Company”) (
NASDAQ: DEFT) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-06637, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired DeFi Technologies securities between May 12, 2025 and November 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Pomerantz Law Firm Announces the Filing of a Class Action Against SLM Corporation and Certain Officers – SLMNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against SLM Corporation (“SLM” or the “Company”) (
NASDAQ: SLM) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-18834, is on behalf of a class consisting of all persons and entities other than Defendants that invested in SLM securities between July 25, 2025 and August 14, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Closed-End Fund Education in Closed-End Corner VideosRYE, N.Y., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Investors looking to learn about the often-overlooked asset class of closed-end funds are invited to visit The Closed-End Corner on Gabelli TV and YouTube.
WittKieffer Appoints Akhil Saklecha, MD, as Managing Director to Advance Global Investor-Backed Healthcare and Life SciencesOak Brook, Illinois, Jan. 20, 2026 (GLOBE NEWSWIRE) -- WittKieffer, the premier executive search and leadership advisory firm dedicated to improving quality of life through impactful leadership, today announced that Akhil Saklecha, MD, has joined the firm as a Managing Director on its Global Investor-Backed Markets team. Dr. Saklecha will help expand the firm’s work with diagnostics, digital health, and medical device companies, early-stage venture capital firms, and the innovation and venture arms of leading medical centers.
Industry Icons & Social Stars: Pacific Northwest Powerhouse, The Nick Shivers Team Joins eXp RealtyThe #1 KW ranked Team & Group in Oregon and Washington & #24 Nationwide for 2025 leaves Keller Williams to leverage eXp's cloud-based scale, bringing 17 agents and massive social influence
Global Virus Network Warns Measles ResurgenceGVN Urges Measles-Mumps-Rubella (MMR) Vaccination for Unvaccinated Children and Adults to Prevent Avoidable Illness and Death
USO Announces MN Vikings Running Back Aaron Jones and NFL Legend Vince Wilfork as Global AmbassadorsTwo NFL stars join forces with the leading nonprofit to support military service members and their families worldwide.
New Research Reveals Key Quality of Life Insights in ADHD ManagementQbtech research analyzing nearly 1,000 patients found a correlation between objective ADHD performance and meaningful changes in daily functioning and well-being
ACGME Announces Request for Grant Proposals for Back to Bedside Project FundingChicago, IL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Accreditation Council for Graduate Medical Education (ACGME) has announced its Request for Grant Proposals for the 2026-2028 cycle of Back to Bedside, an initiative designed to empower residents and fellows to lead and develop transformative and innovative projects to foster meaning and joy in their work by increasing connection with their patients.
Blank Rome Adds Private Equity Litigation Leader Will Weltman as Partner in ChicagoChicago, IL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Blank Rome LLP is pleased to announce that William “Will” S. Weltman has joined the firm’s Chicago office as a partner in the Business Litigation group and Food & Beverage and Technology industry teams. Will brings significant experience in complex litigation and counseling, particularly for private equity firms and their portfolio companies facing intricate and high stakes contractual, trade secret, and technology disputes. He also represents high net worth individuals and family offices in trust and estate litigation. He joins Blank Rome from Reed Smith LLP.
PlanRadar Opens Chicago Office, Expands U.S. OperationsInternational Digital Field Management Platform Poised for Strategic Growth in U.S. Construction and Real Estate Market
Orenda Commodity Services Ltd. acquires Scoular's sunflower and bird food businessWINKLER, Manitoba, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Orenda Commodity Services Ltd. announced today that it has purchased Scoular's sunflower and wild bird food blending business, including a processing facility in Winkler. The sale closed on Jan. 19.
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal ForalumabBOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the peer-reviewed publication of its open-label study in patients with non-active secondary progressive multiple sclerosis (na-SPMS) in Neurology Neuroimmunology & Neuroinflammation, a prestigious journal of the American Academy of Neurology.
IKO Celebrates 75 Years of Proven Performance at IRE 2026Showcasing manufacturing excellence and product innovation at the roofing industry’s premier event
Aegis Resources Ltd. Provides Update on its Optioned Argentinean and Australian ProjectsVancouver, B.C., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Aegis Resources Ltd. (“Aegis” or the “Company”) is pleased to provide shareholders with an update on its optioned projects in Argentina and Australia.
Rezolve Ai Announces $250 Million Registered Direct Offering led by Existing and New Fundamental Institutional InvestorsNEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (
NASDAQ: RZLV), a leader in Agentic Commerce and AI-powered customer engagement, today announced that it has entered into securities purchase agreements led by existing and new fundamental institutional investors for the purchase and sale of 62,500,000 ordinary shares at a purchase price of $4.00 per share, pursuant to a registered direct offering, resulting in gross proceeds of approximately $250 million, before deducting placement agent commissions and other offering expenses. The closing of the offering is expected to occur on or about January 21, 2026, subject to the satisfaction of customary closing conditions.
WellSpan’s nationally-recognized MyWellSpan patient portal and application surpasses 1 million usersThe tool is designed to simplify health care for patients through a personalized self-service experience
HII Selected to Compete on $25.4 Billion Microelectronics Multi-Award ContractMCLEAN, Va., Jan. 20, 2026 (GLOBE NEWSWIRE) -- HII (
NYSE: HII) announced today that its Mission Technologies division is among 12 companies included on a 10-year, $25.4 billion Advanced Technology Support Program V (ATSP5) multiple award indefinite delivery/indefinite quantity contract to provide engineering solutions for electronics and software problems.
NAHQ and Joint Commission Launch Regulatory & Accreditation Micro-Credential to Advance Quality and Patient SafetyNew program combines NAHQ’s healthcare quality competency leadership with Joint Commission’s regulatory and accreditation expertise to deliver practical, real-world accreditation skills
Sequel to My Deadly Daughter Unveils Gruesome Murders in NYCThe chilling sequel to My Deadly Daughter concludes the harrowing saga of murder and mystery, published by Palmetto Publishing, captivating readers once more.
Vitalic Health, powered by HFMA, launches U.S. Healthcare Vitals Tracker to measure affordability, financial sustainability and health outcomesCHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association’s Vitalic Health today released the U.S. Vitals Tracker, a first-of-its-kind tool that measures the health of U.S. healthcare.
ITGR Investors Have Opportunity to Lead Integer Holdings Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Integer Holdings Corporation (“Integer” or “the Company”) (
NYSE: ITGR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
